"The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a hi"...
(Generic versions may still be available.)
Treatment of overdosage is by supportive and symptomatic therapy. In the case of acute overdosage, according to the patient’s condition, supportive therapy may include gastric lavage or emesis.
Systemic fungal infections (see WARNINGS, Fungal infections).
DECADRON tablets are contraindicated in patients who are hypersensitive to any components of this product.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/28/2016
Additional Decadron Information
Decadron - User Reviews
Decadron User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.